{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T16:26:54Z","timestamp":1793896014319,"version":"4.8.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007219","name":"Shanghai Municipal Natural Science Foundation","doi-asserted-by":"publisher","award":["23ZR1449600"],"award-info":[{"award-number":["23ZR1449600"]}],"id":[{"id":"10.13039\/100007219","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82272005"],"award-info":[{"award-number":["82272005"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82171943"],"award-info":[{"award-number":["82171943"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jconrel.2026.115056","type":"journal-article","created":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T23:35:31Z","timestamp":1779838531000},"page":"115056","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Targeting splenic myeloid cells synergizes with CD47 blockade to inhibit postsurgical tumor recurrence and metastasis"],"prefix":"10.1016","volume":"396","author":[{"given":"Weichen","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuexia","family":"Shan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengshan","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huihui","family":"Chai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weifan","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liping","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huixiong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenwen","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengzhong","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2026.115056_bb0005","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1001\/jama.2018.19323","article-title":"Breast cancer treatment a review","volume":"3213","author":"Waks","year":"2019","journal-title":"Jama J. Am. Med. Assoc."},{"key":"10.1016\/j.jconrel.2026.115056_bb0010","first-page":"488","article-title":"Local cancer recurrence: the realities, challenges, and opportunities for new therapies","volume":"686","author":"Mahvi","year":"2018","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.jconrel.2026.115056_bb0015","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.cell.2018.09.035","article-title":"A paradigm shift in cancer immunotherapy: from enhancement to normalization","volume":"1752","author":"Sanmamed","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.jconrel.2026.115056_bb0020","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/nature14292","article-title":"Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer","volume":"5207547","author":"Twyman-Saint Victor","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2026.115056_bb0025","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1038\/s41565-020-00781-4","article-title":"A general strategy towards personalized nanovaccines based on fluoropolymers for post-surgical cancer immunotherapy","volume":"1512","author":"Xu","year":"2020","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2026.115056_bb0030","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.ccell.2020.08.004","article-title":"Challenges and opportunities for pancreatic cancer immunotherapy","volume":"386","author":"Bear","year":"2020","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jconrel.2026.115056_bb0035","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/j.cell.2023.02.020","article-title":"Macrophages at the interface of the co-evolving cancer ecosystem","volume":"1868","author":"Kloosterman","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.jconrel.2026.115056_bb0040","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/s41590-017-0022-x","article-title":"Myeloid-derived suppressor cells coming of age","volume":"192","author":"Veglia","year":"2018","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jconrel.2026.115056_bb0045","doi-asserted-by":"crossref","first-page":"5057","DOI":"10.1158\/0008-5472.CAN-13-3723","article-title":"CSF1\/CSF1R blockade reprograms tumor-infiltrating macrophages and improves response to T-cell checkpoint immunotherapy in pancreatic cancer models","volume":"7418","author":"Zhu","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2026.115056_bb0050","doi-asserted-by":"crossref","first-page":"5380","DOI":"10.1172\/JCI137110","article-title":"Targeting tumor-associated macrophages and granulocytic myeloid-derived suppressor cells augments PD-1 blockade in cholangiocarcinoma","volume":"13010","author":"Loeuillard","year":"2020","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jconrel.2026.115056_bb0055","doi-asserted-by":"crossref","DOI":"10.1038\/s41551-025-01479-5","article-title":"Targeting circulating mechanoresponsive monocytes and macrophages to reduce fibrosis","author":"Chen","year":"2025","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.jconrel.2026.115056_bb0060","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/s41591-021-01233-9","article-title":"Intratumoral heterogeneity in cancer progression and response to immunotherapy","volume":"272","author":"Vitale","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.jconrel.2026.115056_bb0065","doi-asserted-by":"crossref","DOI":"10.1186\/s40425-017-0257-y","article-title":"Colony-stimulating factor 1 receptor (CSF1R) inhibitors in cancer therapy","volume":"5","author":"Cannarile","year":"2017","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.jconrel.2026.115056_bb0070","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/nrc.2016.54","article-title":"The role of myeloid cells in cancer therapies","volume":"167","author":"Engblom","year":"2016","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jconrel.2026.115056_bb0075","doi-asserted-by":"crossref","DOI":"10.1186\/s12929-019-0568-z","article-title":"Tumor-associated macrophages: an accomplice in solid tumor progression","author":"Chen","year":"2019","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.jconrel.2026.115056_bb0080","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/s41568-021-00347-z","article-title":"Systemic immunity in cancer","volume":"216","author":"Hiam-Galvez","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jconrel.2026.115056_bb0085","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/s41577-023-00857-x","article-title":"Splenic stromal niches in homeostasis and immunity","volume":"2311","author":"Alexandre","year":"2023","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2026.115056_bb0090","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.immuni.2013.10.010","article-title":"The spleen in local and systemic regulation of immunity","volume":"395","author":"Bronte","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.jconrel.2026.115056_bb0095","doi-asserted-by":"crossref","DOI":"10.1038\/s41551-025-01533-2","article-title":"Targeting immunosuppressive myeloid cells via implant-mediated slow release of small molecules to prevent glioblastoma recurrence","author":"Kaiser","year":"2025","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.jconrel.2026.115056_bb0100","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/nature15530","article-title":"A perisinusoidal niche for extramedullary haematopoiesis in the spleen","volume":"5277579","author":"Inra","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2026.115056_bb0105","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1038\/s41591-020-0892-6","article-title":"Systemic dysfunction and plasticity of the immune macroenvironment in cancer models","volume":"267","author":"Allen","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.jconrel.2026.115056_bb0110","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.immuni.2019.12.018","article-title":"Tumor immunology and tumor evolution: intertwined histories","volume":"521","author":"Galon","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.jconrel.2026.115056_bb0115","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abe7853","article-title":"A modular approach toward producing nanotherapeutics targeting the innate immune system","author":"van Leent","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jconrel.2026.115056_bb0120","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41581-022-00633-5","article-title":"Trained immunity \u2014 basic concepts and contributions to immunopathology","volume":"191","author":"Ochando","year":"2023","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.jconrel.2026.115056_bb0125","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.cell.2020.09.058","article-title":"Innate immune training of granulopoiesis promotes anti-tumor activity","volume":"1833","author":"Kalafati","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.jconrel.2026.115056_bb0130","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.cell.2017.11.034","article-title":"Modulation of myelopoiesis progenitors is an integral component of trained immunity","volume":"17212","author":"Mitroulis","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.jconrel.2026.115056_bb0135","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.cell.2020.09.059","article-title":"Trained immunity-promoting nanobiologic therapy suppresses tumor growth and potentiates checkpoint inhibition","volume":"1833","author":"Priem","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.jconrel.2026.115056_bb0140","article-title":"KK2DP7 stimulates CD11b+ cell populations in the spleen to elicit trained immunity for anti-tumor therapy","author":"Zhang","year":"2025","journal-title":"Adv. Sci."},{"key":"10.1016\/j.jconrel.2026.115056_bb0145","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aaw6870","article-title":"Red blood cell-derived nanoerythrosome for antigen delivery with enhanced cancer immunotherapy","author":"Han","year":"2019","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jconrel.2026.115056_bb0150","article-title":"A splenic-targeted versatile antigen courier: iPSC wrapped in coalescent erythrocyte-liposome as tumor nanovaccine","author":"Zhai","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jconrel.2026.115056_bb0155","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/s41578-021-00413-w","article-title":"Regulating trained immunity with nanomedicine","volume":"76","author":"van Leent","year":"2022","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.jconrel.2026.115056_bb0160","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aau6085","article-title":"Structure and function of the immune system in the spleen","author":"Lewis","year":"2019","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.jconrel.2026.115056_bb0165","doi-asserted-by":"crossref","first-page":"9574","DOI":"10.1073\/pnas.1806501115","article-title":"Mechanics of diseased red blood cells in human spleen and consequences for hereditary blood disorders","volume":"11538","author":"Li","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jconrel.2026.115056_bb0170","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1038\/s41551-023-01050-0","article-title":"Resolving sepsis-induced immunoparalysis via trained immunity by targeting interleukin-4 to myeloid cells","volume":"79","author":"Schrijver","year":"2023","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.jconrel.2026.115056_bb0175","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/s41573-019-0025-4","article-title":"Therapeutic targeting of trained immunity","volume":"187","author":"Mulder","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2026.115056_bb0180","article-title":"Preparation and culture of bone marrow-derived macrophages from mice for functional analysis","volume":"21","author":"Toda","year":"2021","journal-title":"STAR Protoc."},{"key":"10.1016\/j.jconrel.2026.115056_bb0185","article-title":"In vitro protocol demonstrating five functional steps of trained immunity in mice: implications on biomarker discovery and translational research","volume":"4410","author":"Gonzalez-Perez","year":"2025","journal-title":"Cell Rep."},{"key":"10.1016\/j.jconrel.2026.115056_bb0190","doi-asserted-by":"crossref","first-page":"3425","DOI":"10.1172\/JCI97973","article-title":"Spleen mediates a distinct hematopoietic progenitor response supporting tumor-promoting myelopoiesis","volume":"1288","author":"Wu","year":"2018","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jconrel.2026.115056_bb0195","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/s41565-018-0319-4","article-title":"In situ sprayed bioresponsive immunotherapeutic gel for post-surgical cancer treatment","volume":"141","author":"Chen","year":"2019","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2026.115056_bb0200","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1126\/science.aaf2784","article-title":"Metastasis as an evolutionary process","volume":"3526282","author":"Turajlic","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2026.115056_bb0205","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aar1916","article-title":"Extended release of perioperative immunotherapy prevents tumor recurrence and eliminates metastases","author":"Park","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jconrel.2026.115056_bb0210","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.immuni.2020.07.008","article-title":"CD47 ligation repositions the inhibitory receptor SIRPA to suppress integrin activation and phagocytosis","volume":"532","author":"Morrissey","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.jconrel.2026.115056_bb0215","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1093\/annonc\/mdz006","article-title":"The macrophage \u2018do not eat me\u2019 signal, CD47, is a clinically validated cancer immunotherapy target","volume":"303","author":"Takimoto","year":"2019","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.jconrel.2026.115056_bb0220","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/s41568-019-0183-z","article-title":"Phagocytosis checkpoints as new targets for cancer immunotherapy","volume":"1910","author":"Feng","year":"2019","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jconrel.2026.115056_bb0225","article-title":"Targeting the myeloid checkpoint receptor SIRP\u03b1 potentiates innate and adaptive immune responses to promote anti-tumor activity","volume":"131","author":"Kuo","year":"2020","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.jconrel.2026.115056_bb0230","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1016\/j.cell.2021.02.048","article-title":"Genetically engineered myeloid cells rebalance the core immune suppression program in metastasis","volume":"1848","author":"Kaczanowska","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.jconrel.2026.115056_bb0235","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1073\/pnas.1113744109","article-title":"Origins of tumor-associated macrophages and neutrophils","volume":"1097","author":"Cortez-Retamozo","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926004591?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926004591?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T15:58:24Z","timestamp":1793894304000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365926004591"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":47,"alternative-id":["S0168365926004591"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.115056","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting splenic myeloid cells synergizes with CD47 blockade to inhibit postsurgical tumor recurrence and metastasis","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.115056","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115056"}}